On Pharma Importadora, Exportadora E Distribuidora De Medicamentos Ltda.

This study is testing a new version of an existing treatment called V-IMMUNE for people with immune thrombocytopenia (ITP), a condition where the immune system attacks platelets, increasing the risk of bleeding. The goal is to see if two daily infusions of V-IMMUNE can safely rai…

This study is testing a new immunoglobulin product called V-IMMUNE® for people with primary immunodeficiency (PID), a condition where the body cannot make enough antibodies to fight infections. About 50 participants, aged 2 and older who are already receiving similar treatments, …